ANI Pharmaceuticals, Inc., announced that the Company received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for Fluoxetine Oral Solution, USP 20 mg/5 mL. ANI
Found this useful? Share it with your team.
